Sort
261,768 grants matching “gene therapy”
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND
$1,843,400Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2015 · DA
VPS72 controls Treg cell stability and adaptation to tumor microenvironment
$1,843,396Qing-Sheng Mi · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA
LEAD PROJECT 1: PHENYLKETONURIA (PKU)
$1,843,290Kiran Musunuru · Children'S Hosp Of Philadelphia · U19 · FY2025 · NS
Mechanisms of Breast Development and Carcinogenesis
$1,843,160Robert A Weinberg · Whitehead Institute For Biomedical Res · P01 · FY2015 · CA
NK cells, their receptors, transplantation and cancer therapy
$1,842,904Jeffrey S Miller · University Of Minnesota · P01 · FY2017 · CA
NATIONAL GENE VECTOR LABORATORY AT INDIANA UNIVERSITY
$1,842,795Kenneth G Cornetta · Indiana Univ-Purdue Univ At Indianapolis · U42 · FY2006 · RR
Evolutionary dynamics and microenvironmental determinants of metastatic breast cancer
$1,842,753Christina N Curtis · Stanford University · U54 · FY2022 · CA
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
$1,842,541Ramaprasad Srinivasan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Processing and Repair of DNA Crosslinks
$1,842,466Richard D Wood · University Of Tx Md Anderson Can Ctr · P01 · FY2021 · CA
PIDTC Administrative Unit
$1,842,349Jennifer Maxwell Puck · University Of California, San Francisco · U54 · FY2021 · AI
GENE THERAPY FOR SICKLE CELL ANEMIA
$1,841,786Yeshiva University · P01 · FY2001 · HL
Rescuing the Fragile X Syndrome by Resetting Translational Homeostasis
$1,841,627Joel D Richter · Univ Of Massachusetts Med Sch Worcester · U54 · FY2016 · HD
Asthma and Nocturnal Hypoxemia in Sickle Cell Anemia
$1,841,516Michael Rutledge Debaun · Washington University · R01 · FY2008 · HL
Non-Coding Genetic Vulnerabilities in Human Photoreceptor Function and Disease
$1,840,998Timothy Joel Cherry · Seattle Children'S Hospital · R01 · FY2025 · EY
Cholinergic Mechanisms of Gait Dysfunction in Parkinson's Disease
$1,840,995William T Dauer · University Of Michigan At Ann Arbor · P50 · FY2016 · NS
Model Systems Core (MODS Core)
$1,840,878Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2024 · AI
Translational Gene Therapy for Rhodopsin Autosomal Dominant Retinitis Pigmentosa
$1,840,747William A. Beltran · University Of Pennsylvania · R24 · FY2015 · EY
DNA Sequencing and FACS Core Facilities
$1,840,527Paul Robbins · Division Of Basic Sciences - Nci · ZIC · FY2025 · CA
Manufacture of an intracerebroventricular Enzyme Replacement Therapy for CLN1 Batten Disease
$1,840,246Sean Ekins · Collaborations Pharmaceuticals, Inc. · SB1 · FY2024 · NS
Emory University Lung Cancer SPORE
$1,839,911Suresh S Ramalingam · Emory University · P50 · FY2022 · CA
Emory University Lung Cancer SPORE
$1,839,911Suresh S Ramalingam · Emory University · P50 · FY2023 · CA
Comprehensive Sickle Cell Center
$1,839,707St. Jude Children'S Research Hospital · U54 · FY2003 · HL
Bio-Analysis Core
$1,839,495George A Kuchel · University Of Connecticut Sch Of Med/Dnt · U54 · FY2024 · AG
Molecular Pathogenesis of Neoplasia
$1,839,017John Heiss · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
STEM CELL THERAPY OF CONGENITAL DEFECTS IN HEMATOPOIESIS
$1,838,132Dana-Farber Cancer Institute · P50 · FY2004 · HL